Ricursive Intelligence, founded by two former Google researchers and valued at $4 billion, is among several efforts to ...

While standard models suffer from context rot as data grows, MIT’s new Recursive Language Model (RLM) framework treats ...

Leaders don’t fail from complexity overload. They fail from pretending it’s simple, then engineering systems that move ...

We need a definition that aligns AI development with India’s legal and disability jurisprudence, so that “AI for all” does ...

AI has officially moved from a theoretical promise to an essential everyday element, powering industries, shaping policy, and ...

Kevin Cann’s "Platonic Surrealism" hits #1 on Amazon, bridging Neoplatonism and UAP phenomena with a practical ...

A small number of cancer cells with the ability to change their identities and behaviors appear to be a key driver of cancer progression and its ability to evolve resistance to treatment, Memorial ...

The inflation-adjusted cost of developing a new drug now doubles roughly every nine years. To reverse this trend, the ...

GenAI can do more than generate images – it can spark design students’ ability to imagine objects and spaces in 3D. Here’s ...

Device assistants are turning into orchestrators, going beyond answering questions to taking actions. For journalism, that ...

Last week, two of the biggest and oldest companies in the burgeoning AI drug discovery space announced a surprise merger. In a roughly 75-25 deal, Recursion Bio and Exscientia will (if the merger goes ...